Follow
SYRIGOS KONSTANTINOS N.
SYRIGOS KONSTANTINOS N.
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
First-line nivolumab in stage IV or recurrent non–small-cell lung cancer
DP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ...
New England Journal of Medicine 376 (25), 2415-2426, 2017
20472017
Nivolumab plus ipilimumab in advanced non–small-cell lung cancer
MD Hellmann, L Paz-Ares, R Bernabe Caro, B Zurawski, SW Kim, ...
New England Journal of Medicine 381 (21), 2020-2031, 2019
14292019
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy …
EB Garon, TE Ciuleanu, O Arrieta, K Prabhash, KN Syrigos, T Goksel, ...
The Lancet 384 (9944), 665-673, 2014
11602014
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
8362014
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ...
Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013
6442013
Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action
A Kollias, KG Kyriakoulis, E Dimakakos, G Poulakou, GS Stergiou, ...
British journal of haematology 189 (5), 846-847, 2020
5102020
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal …
J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, ...
British journal of cancer 94 (6), 798-805, 2006
4732006
Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer
V Michalaki, K Syrigos, P Charles, J Waxman
British journal of cancer 90 (12), 2312-2316, 2004
4672004
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
JC Soria, E Felip, M Cobo, S Lu, K Syrigos, KH Lee, E Göker, ...
The lancet oncology 16 (8), 897-907, 2015
4282015
Cell adhesion molecules: role and clinical significance in cancer
N Makrilia, A Kollias, L Manolopoulos, K Syrigos
Cancer investigation 27 (10), 1023-1037, 2009
3982009
Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 …
SG Deftereos, G Giannopoulos, DA Vrachatis, GD Siasos, SG Giotaki, ...
JAMA network open 3 (6), e2013136-e2013136, 2020
3882020
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
K Nakagawa, EB Garon, T Seto, M Nishio, SP Aix, L Paz-Ares, CH Chiu, ...
The Lancet Oncology 20 (12), 1655-1669, 2019
3412019
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
3342015
Objective measurement and clinical significance of TILs in non–small cell lung cancer
KA Schalper, J Brown, D Carvajal-Hausdorf, J McLaughlin, V Velcheti, ...
Journal of the National Cancer Institute 107 (3), dju435, 2015
3272015
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer
P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ...
Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013
3192013
Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery
D Alexiou, AJ Karayiannakis, KN Syrigos, A Zbar, A Kremmyda, I Bramis, ...
European Journal of Cancer 37 (18), 2392-2397, 2001
2632001
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic …
GP Stathopoulos, K Syrigos, G Aravantinos, A Polyzos, P Papakotoulas, ...
British journal of cancer 95 (5), 587-592, 2006
2512006
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small …
LG Paz-Ares, B Biesma, D Heigener, J Von Pawel, T Eisen, J Bennouna, ...
J Clin Oncol 30 (25), 3084-3092, 2012
2432012
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial
V Georgoulias, A Ardavanis, X Tsiafaki, A Agelidou, P Mixalopoulou, ...
Journal of clinical oncology 23 (13), 2937-2945, 2005
2382005
Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery
AJ Karayiannakis, KN Syrigos, A Polychronidis, A Zbar, G Kouraklis, ...
Annals of surgery 236 (1), 37, 2002
2352002
The system can't perform the operation now. Try again later.
Articles 1–20